TelePeptide Health
Informed Medical Consent
Effective Date: April 3, 2026 · Last Revised: April 13, 2026
Please read this consent carefully. By submitting an intake form or proceeding with any TelePeptide Health program, you agree to the terms of this consent. If you have questions, contact help@telepeptide.org before proceeding.
1. Nature of Telehealth Services
TelePeptide Health provides telehealth services that connect you with licensed Florida physicians for medical evaluation and, where clinically appropriate, prescribing. Telehealth means your evaluation may occur entirely through digital communication — written intake forms, asynchronous provider review, and secure messaging — without an in-person visit. By submitting an intake request you consent to this model of care and acknowledge you understand the following: (a) telehealth has inherent limitations compared to in-person care, including an inability to perform physical examinations; (b) your physician may require additional information, labs, or an in-person visit before prescribing; and (c) there is no guarantee a prescription will be issued based on your intake alone.
2. No Guarantee of Prescription or Treatment
Submitting an intake form, joining the waitlist, or making a payment does not guarantee you will receive a prescription, consultation, or medication. All prescribing decisions are made solely by the licensed independent physician assigned to your case based on their professional medical judgment. TelePeptide Health does not direct or influence prescribing decisions. A physician may decline to prescribe for any clinical reason, including but not limited to: contraindications, incomplete information, insufficient medical history, or clinical ineligibility for a specific medication or program.
3. Compound Medications — Informed Consent
Some programs may involve compounded medications, including but not limited to compounded semaglutide, tirzepatide, BPC-157, CJC-1295/Ipamorelin, and Sermorelin. By proceeding you acknowledge and consent to the following: (a) Compounded medications are not FDA-approved finished drug products. They are prepared by licensed 503A or 503B compounding pharmacies but have not undergone the same FDA review process as brand-name drugs. (b) The FDA has not independently verified the safety, efficacy, potency, or sterility of compounded versions of these medications. (c) Compounded medications may carry different risk profiles than FDA-approved equivalents. (d) You have the right to ask your physician about alternatives, including FDA-approved branded medications, before agreeing to a compounded formulation. (e) You will discuss the specific risks and benefits of any prescribed compound with your physician prior to dispensing.
4. Off-Label Use
Some medications prescribed through TelePeptide programs may be used in an off-label manner — meaning for a purpose, dose, or patient population not specifically approved by the FDA. Off-label prescribing is legal, widely practiced, and may reflect emerging clinical evidence. By proceeding you acknowledge that your physician has disclosed or will disclose any off-label aspects of your treatment plan, and you consent to off-label use where your physician determines it is appropriate based on current clinical evidence.
5. Risks and Side Effects
All medications and medical programs carry potential risks and side effects. GLP-1 agonists (semaglutide, tirzepatide) may cause nausea, vomiting, diarrhea, constipation, headache, fatigue, injection site reactions, and in rare cases pancreatitis or thyroid effects. Peptide therapies may have other profiles disclosed by your physician. You acknowledge that: (a) your physician will review known risks with you; (b) you must report any adverse reactions promptly; (c) you will follow all instructions provided by your prescribing physician; and (d) TelePeptide Health is not liable for clinical outcomes, adverse reactions, or events arising from your treatment.
6. Not an Emergency Service
TelePeptide Health is not an emergency medical service. If you are experiencing a medical emergency, a life-threatening reaction, or severe adverse effects from any medication, call 911 or go to the nearest emergency room immediately. Do not contact TelePeptide through this platform for emergency care.
7. Accurate Medical History
You consent to providing complete, accurate, and truthful medical history, including current medications, allergies, prior diagnoses, and family history. You understand that inaccurate or incomplete information could result in harm and that TelePeptide Health and its contracted physicians are not liable for outcomes resulting from information you withheld or misrepresented.
8. Sharing Information with Care Partners
By submitting an intake request you consent to TelePeptide Health sharing your personal and health information with: (a) the licensed Florida physician assigned to your case; (b) the compounding pharmacy filling your prescription; (c) laboratory partners where bloodwork or testing is required; and (d) other contracted healthcare providers involved in your care. All such sharing is governed by HIPAA-compliant Business Associate Agreements. See our Notice of Privacy Practices at /privacy-practices for full details.
9. Withdrawal of Consent
You may withdraw your consent to telehealth services at any time by notifying us at help@telepeptide.org. Withdrawal of consent will stop future services but will not affect the legality of any services already rendered or any payment obligations already incurred. Medical records will be retained in accordance with Florida law regardless of withdrawal.
10. Acknowledgment
By submitting an intake form or proceeding with any TelePeptide Health program, you confirm that: (a) you have read and understood this Informed Consent; (b) you have had the opportunity to ask questions; (c) you voluntarily consent to the services described; and (d) you are at least 18 years of age and legally competent to give consent.
TelePeptide Health · 2077 Center Ave, Apt 9J, Fort Lee, NJ 07024 · help@telepeptide.org